Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Judong Lee,1,3,
Ee Wern Su,1,3,
Chen Zhu,4
Sarah Hainline,1
Jiayao Phuah,1,3
Jamie A. Moroco,2
Thomas E. Smithgall,2
Vijay K. Kuchroo,4, and
Lawrence P. Kane1*
Department of Immunology,1
Department of Microbiology and Molecular Genetics,2
Graduate Program in Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261,3
Center for Neurologic Disease, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 021154
Received for publication 7 March 2011.
Revision received 31 March 2011.
Accepted for publication 22 July 2011.
Abstract:
The transmembrane protein Tim-3 has been shown to negativelyregulate T-cell-dependent immune responses and was recentlydemonstrated to be associated with the phenomenon of immuneexhaustion, which can occur as a consequence of chronic viralinfection. Unlike other negative regulators of T-cell function(e.g., PD-1), Tim-3 does not contain any obvious inhibitorysignaling motifs. We have found that ectopic expression of Tim-3in T cells leads to enhancement of T-cell receptor (TCR)-dependentsignaling pathways, which was observed at the level of transcriptionalreporters and endogenous cytokine production. We have exploitedthis observation to dissect what elements within the cytoplasmictail of Tim-3 are required for coupling to downstream signalingpathways. Here we have demonstrated that two of the more membrane-proximalcytoplasmic tail tyrosines are required for Tim-3 signalingto T-cell activation pathways in a redundant fashion. Furthermore,we show that Tim-3 can directly bind to the Src family tyrosinekinase Fyn and the p85 phosphatidylinositol 3-kinase (PI3K)adaptor. Thus, at least under conditions of short-term stimulation,Tim-3 can augment T-cell activation, although this effect canbe blocked by the inclusion of an agonistic antibody to Tim-3.These findings should help further the study of Tim-3 functionin other physiological settings, such as those that lead toimmune exhaustion.
* Corresponding author. Mailing address: Department of Immunology, University of Pittsburgh School of Medicine, BST E-1056, 200 Lothrop St., Pittsburgh, PA 15261. Phone: (412) 648-8947. Fax: (412) 383-8096. E-mail: lkane{at}pitt.edu.
These two authors contributed equally.
Published ahead of print on 1 August 2011.
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
John F. Foley (20 September 2011) Sci. Signal.4 (191), ec262.
[DOI: 10.1126/scisignal.4191ec262] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response.
X. Yang, X. Jiang, G. Chen, Y. Xiao, S. Geng, C. Kang, T. Zhou, Y. Li, X. Guo, H. Xiao, et al. (2013)
J. Immunol.
190, 2068-2079
|Abstract »|Full Text »|PDF »
Enhanced Tim3 Activity Improves Survival after Influenza Infection.
J. L. Cho, M. I. Roche, B. Sandall, A. L. Brass, B. Seed, R. J. Xavier, and B. D. Medoff (2012)
J. Immunol.
189, 2879-2889
|Abstract »|Full Text »|PDF »
Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention.
W. J. Norde, W. Hobo, R. van der Voort, and H. Dolstra (2012)
Blood
120, 728-736
|Abstract »|Full Text »|PDF »
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.
L. C. Ndhlovu, S. Lopez-Verges, J. D. Barbour, R. B. Jones, A. R. Jha, B. R. Long, E. C. Schoeffler, T. Fujita, D. F. Nixon, and L. L. Lanier (2012)
Blood
119, 3734-3743
|Abstract »|Full Text »|PDF »
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
M. K. Gleason, T. R. Lenvik, V. McCullar, M. Felices, M. S. O'Brien, S. A. Cooley, M. R. Verneris, F. Cichocki, C. J. Holman, A. Panoskaltsis-Mortari, et al. (2012)
Blood
119, 3064-3072
|Abstract »|Full Text »|PDF »